We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Ure6.0
Urea Research
Mostly mechanism / observational
9 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Urea studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1998–2025 with a typical study size of 60 participants.
Based on 9 studies · 2 meta-analyses · 7 RCTs · 8,476 total participants
Confidence
High confidence
By outcome
Hair & nails
Too few graded studies2 studies
Skin healthSignificant improvement in xerosis signs over 4 weeks, though not reliably better than a plain cheap moisturiser · 2-4 weeks · Reduced scaling and hyperkeratosis in ichthyosis and hyperkeratotic skin; removes scale before other treatments at 30% · 4-8 weeks
Too few graded studies1 study
Active research area
5 studies in the last 5 years · Latest meta-analysis: 2022
199820112025
1Meta-AnalysisCited 206×n=6,603 · very large study2017
In plain English: Moisturiser use yielded a lower SCORAD than no moisturiser across three studies and 276 participants, but the minimal important difference was UNMET.
van Zuuren EJ, et al. · Cochrane Database Syst Rev (2017)
The Cochrane review that sets the context urea has to be judged in: 77 studies, 6603 participants.
⚠️ Statistically present, clinically small: SCORAD improved but the MINIMAL IMPORTANT DIFFERENCE was not met.
Moisturisers prolonged time to flare, reduced flare numbers and reduced the topical corticosteroid needed — findings the review grades as low to moderate quality.
2Meta-AnalysisCited 10×n=1,387 · large study2022
In plain English: Across seven trials and 1387 patients, the PROPHYLACTIC subgroup showed significantly lower grade 2 or higher hand-foot syndrome with urea cream (RR 0.72, 95% CI 0.58-0.90), while the reduction in any-grade hand-foot syndrome was not significant (RR 0.79, 95% CI 0.58-1.08).
Chen M, et al. · Cancer Nurs (2022)
Seven trials, 1387 patients, PROSPERO-registered. Both risk ratios below come from the prophylactic subgroup, not the whole pool.
The significant result is for SEVERE disease: grade 2 or above, RR 0.72 (95% CI 0.58-0.90).
⚠️ Any-grade hand-foot syndrome was NOT significantly reduced — RR 0.79 with a confidence interval crossing 1 (0.58-1.08).
3RCTCited 2×n=216 · medium study2025
In plain English: Any-grade hand-foot syndrome was reported by 68 of 109 patients (62.4%) on usual care and 60 of 107 (56%) using urea cream (p = 0.36); grade 3 occurred in 47.7% versus 41.1% (p = 0.34).
Sookprasert A, et al. · BMC Cancer (2025)
THE COUNTER-EVIDENCE: a 216-patient randomised trial in which every prespecified endpoint was null.
Every endpoint was null: any-grade HFS 62.4% vs 56% (p = 0.36), grade 3 47.7% vs 41.1% (p = 0.34), capecitabine modification 18.3% vs 15.9% (p = 0.89), and similar time to onset.
The authors’ own summary: urea cream "did not prevent capecitabine-associated HFS, reduce capecitabine modification, and delay HFS onset".
4RCTCited 37×n=60 · small study1998
In plain English: In 60 children treating one side with 10% urea lotion and the other with the urea-free lotion base, global severity fell from 4.8 to 2.0 on the urea side and from 4.8 to 2.5 on the base side, with 8-week response rates of 78% and 72%.
Küster W, et al. · Dermatology (1998)
A strong design for a small study: SEMILATERAL, so each child is their own control, with an untreated control area on each side as well.
Urea beat its own vehicle — 4.8 to 2.0 versus 4.8 to 2.5 on a visual analogue scale over 8 weeks.
⚠️ The margin is narrow: 8-week response rates were 78% for the urea lotion against 72% for the plain lotion base, and the vehicle moved severity from 4.8 to 2.5 on its own.
5RCTCited 2×n=41 · small study2018
In plain English: Comparing 25% urea cream with sorbolene over 28 days, both improved foot xerosis significantly, and the difference between them was not significant (effect size -0.48, 95% CI -1.16 to 0.22).
Parker J, et al. · J Am Podiatr Med Assoc (2018)
⚠️ THE PRICE QUESTION, asked directly: 25% urea cream against plain sorbolene, a basic cheap moisturiser.
Both worked. Mean improvement 3.50 (95% CI 2.80-4.20) for urea and 2.90 (95% CI 2.00-3.80) for sorbolene.
⚠️ The difference was NOT significant (P ≤ .09; effect size -0.48, 95% CI -1.16 to 0.22).
6RCTCited 11×n=40 · small study2024
In plain English: Preparing the skin at home with keratolytics including 30% urea cream, instead of curettage, gave a -54.7% lesion reduction against -58.7% with curettage, with no statistically significant difference in efficacy or patient satisfaction.
Tests urea’s KERATOLYTIC property as a substitute for a painful procedure — removing scale so a photosensitiser can penetrate.
The comparator is curettage, which patients find painful and which causes stinging when the photosensitiser is applied to freshly curetted skin.
The result is a NULL and that is the point: -54.7% without curettage versus -58.7% with it, and the differences in efficacy and patient satisfaction were not statistically significant.
7RCTCited 18×n=60 · small study1998
In plain English: A cream combining 2% butenafine hydrochloride with 20% urea cured 88% of big-toenail onychomycosis against 0% on placebo (p < 0.0001), with no relapse among cured patients over a year of follow-up.
Syed TA, et al. · J Dermatol (1998)
⚠️ READ THE COMBINATION CAREFULLY: butenafine is the ANTIFUNGAL. Urea is there at 20% for keratinolysis — softening the nail so the drug can reach the infection.
The result is striking (88% vs 0%, p < 0.0001) but it is evidence for the combination, NOT for urea curing a fungal infection.
60 patients with more than 25% big-toenail involvement, applied twice daily under occlusion for one week.
8RCTCited 1×n=59 · small study2025
In plain English: At 24 weeks, SCIO response rates were 42.86% for laser alone, 66.67% for urea occlusion alone and 61.11% for the combination; mycological cure rates were 26.52%, 53.33% and 56.52% respectively.
Wang Y, et al. · Lasers Med Sci (2025)
Places urea occlusion against a device therapy, with twice-daily miconazole given to EVERY arm.
Urea occlusion alone was numerically higher than laser alone on SCIO response (66.67% vs 42.86%) and mycological cure (53.33% vs 26.52%), but that between-group gap was NOT among the differences reported as significant — the abstract’s own conclusion favours the combination.
⚠️ The antifungal is common to all three arms, so this measures urea occlusion as a penetration-enhancing ADJUNCT, not as a treatment on its own.
9RCTCited 1×n=10 · very small study2024
In plain English: In 20 feet belonging to 10 patients with diabetic foot syndrome, 19 feet (95%) showed improved skin quality after either of two 10% urea creams purchased from pharmacies and supermarkets — the authors conclude they improve foot skin quality "regardless of their cost".
Lázaro-Martínez JL, et al. · Adv Skin Wound Care (2024)
The practical question asked directly, and the conclusion is explicit: creams containing 10% urea purchased in SUPERMARKETS improve foot skin quality "regardless of their cost".
Reduced xerosis, hyperkeratosis and preulcerative signs such as subkeratotic bruising and redness on the dorsum of the toes.
⚠️ VERY small: 10 patients, 20 feet, single centre. Treat it as a pilot.